ADAM17 and breast cancer: Only in a very severe case of NM, a 53-year old patient with progressive breast cancer with severe neurologic deficits and diagnosis based on CSF cytology, we were able to detect MMP-9 and TNF-RI (as ADAM17 substrate) by ELISA (Additional file 1: Fig. S4).